(Q47779956)

5 February 2018

title

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study (English)

1 reference

5 February 2018

0 references

0 references

1 reference

1 reference

Kurt A Jellinger

1

1 reference

5 February 2018

publication date

5 July 2003

1 reference

5 February 2018

published in

Acta Neuropathologica

1 reference

5 February 2018

volume

106

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

191-201

1 reference

5 February 2018

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Amygdala pathology in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Alpha-synuclein and the Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

THE PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Accuracy of diagnosis in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

The anterior olfactory nucleus in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

Restricted occurrence of Lewy bodies in the dorsal vagal nucleus in a patient with late-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-003-0725-Y

10.1007/S00401-003-0725-Y

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018